Mechanisms of Adrenomedullin-Induced Dilatation of Cerebral Arterioles
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 28 (1) , 181-185
- https://doi.org/10.1161/01.str.28.1.181
Abstract
Adrenomedullin is a recently discovered vasoactive peptide that is structurally related to calcitonin gene-related peptide (CGRP). Adrenomedullin is produced by vascular endothelium and smooth muscle and is present in the brain. The goals of this study were to determine (1) whether adrenomedullin produces dilatation of cerebral arterioles and whether this effect is mediated by activation of CGRP receptors and (2) whether vasodilatation to adrenomedullin was mediated by K+ channels. Diameter of cerebral arterioles (mean +/- SE baseline, 46 +/- 1 microns) was measured using a closed cranial window in anesthetized rats. Application of rat adrenomedullin (10(-7) and 10(-6) mol/L) increased vessel diameter by 16 +/- 3% and 45 +/- 8% (n = 5), respectively. Vasodilator responses to repeated application of adrenomedullin were reproducible. Pretreatment of cerebral arterioles with the specific CGRP1 receptor antagonist CGRP-(8-37) (5 x 10(-7) mol/L) selectively inhibited the vasodilator responses to adrenomedullin without inhibiting responses to ADP (10(-5) to 10(-3) mol/L). Responses to adrenomedullin (10(-7) and 10(-6) mol/L) were 14 +/- 1% and 40 +/- 3% before and 2 +/- 2% and 6 +/- 1% after CGRP-(8-37), respectively (P < .01). Glibenclamide (10(-6) mol/L), an inhibitor of ATP-sensitive K+ channels, reduced the responses to adrenomedullin without attenuating responses to ADP. Responses to adrenomedullin were 19 +/- 4% and 35 +/- 6% before and 6 +/- 3% and 19 +/- 5% after glibenclamide, respectively (P < .05). Iberiotoxin (10(-7) mol/L), an inhibitor of calcium-dependent K+ channels, also significantly attenuated responses to adrenomedullin and did not inhibit vasodilatation to papaverine. Responses to adrenomedullin were 16 +/- 2% and 55 +/- 8% before and 12 +/- 4% and 26 +/- 3% after iberiotoxin, respectively (P < .01 for 10(-6) mol/L adrenomedullin). Adrenomedullin produces substantial dilatation of cerebral arterioles in vivo, and the response is mediated in large part by activation of CGRP1 receptors. Cerebral vasodilatation to adrenomedullin appears to be dependent on activation of K+ channels.Keywords
This publication has 26 references indexed in Scilit:
- Endotoxin Markedly Elevates Plasma Concentration and Gene Transcription of Adrenomedullin in RatBiochemical and Biophysical Research Communications, 1995
- Receptors for adrenomedullin in human vascular endothelial cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Interleukin-1, Tumor Necrosis Factor and Lipopolysaccharide Additively Stimulate Production of Adrenomedullin in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1995
- Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.Journal of Clinical Investigation, 1994
- Increased endothelin-1 in the rabbit model of middle cerebral artery occlusionNeuroscience Letters, 1994
- Adrenomedullin Stimulates Cyclic AMP Formation in Rat Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasmaFEBS Letters, 1994
- Transient forebrain ischemia alters acutely endothelin receptor density and immunoreactivity in gerbil brainLife Sciences, 1993
- Vasodilator Effect of Adrenomedullin and Calcitonin Gene-Related Peptide Receptors in Rat Mesenteric Vascular BedsBiochemical and Biophysical Research Communications, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993